作者
Fernando Magro, João Sabino, Francesca Rosini, Monika Tripathi, Paula Borralho, Paméla Baldin, Silvio Danese, Ann Driessen, Ilyssa O Gordon, Marietta Iacucci, Nurulamin Noor, Magali Svrcek, Laurent Peyrin-Biroulet, Roger Feakins
发表日期
2022/6/1
期刊
Journal of Crohn's and Colitis
卷号
16
期号
6
页码范围
876-883
出版商
Oxford University Press
简介
In inflammatory bowel disease [IBD], mucosal healing is a major therapeutic target and a reliable predictor of clinical course. However, endoscopic mucosal healing is not synonymous with histological healing, and the additional benefits of including histological remission as a target are unclear. In Crohn´s disease [CD], there are few studies highlighting the value of histological remission as a therapeutic target. Histological activity can persist in CD patients who are in endoscopic remission, and the absence of histological activity may be associated with lower relapse rates. Therefore, standardisation of procedures to evaluate CD histological activity is desirable. Topics that would benefit from standardisation and harmonisation include biopsy procedures, biopsy processing techniques, the content of histological scores, and the definitions of histological remission, histological response, and histological activity. In …
引用总数
学术搜索中的文章
F Magro, J Sabino, F Rosini, M Tripathi, P Borralho… - Journal of Crohn's and Colitis, 2022